Rafael Cantón

Author PubWeight™ 146.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008 6.21
2 Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009 3.48
3 Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 2002 3.23
4 Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008 3.23
5 Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol 2008 2.96
6 Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004 2.90
7 Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother 2008 2.88
8 Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents 2007 2.61
9 Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 2006 2.49
10 Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother 2011 2.42
11 Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob Agents Chemother 2006 1.79
12 Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-alpha, and IncFI groups. Antimicrob Agents Chemother 2006 1.79
13 [Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery]. Arch Bronconeumol 2008 1.75
14 Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int J Antimicrob Agents 2009 1.74
15 Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis 2007 1.70
16 Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. Antimicrob Agents Chemother 2009 1.70
17 High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008 1.64
18 Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6')-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob Agents Chemother 2006 1.64
19 Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanisms. Diagn Microbiol Infect Dis 2006 1.54
20 Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 2008 1.53
21 [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)]. Enferm Infecc Microbiol Clin 2003 1.53
22 [Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005)]. Enferm Infecc Microbiol Clin 2008 1.52
23 Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 2006 1.52
24 Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother 2005 1.50
25 [Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)]. Enferm Infecc Microbiol Clin 2008 1.43
26 High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients. J Antimicrob Chemother 2002 1.41
27 Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol 2011 1.35
28 Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother 2010 1.33
29 Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J Antimicrob Chemother 2011 1.29
30 Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004. J Infect 2007 1.27
31 High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004 1.27
32 Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog 2010 1.26
33 Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J Clin Microbiol 2004 1.25
34 Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009 1.25
35 Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob Agents Chemother 2005 1.24
36 Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue? J Clin Microbiol 2011 1.22
37 Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010 1.19
38 Antibiotic resistance integrons and extended-spectrum {beta}-lactamases among Enterobacteriaceae isolates recovered from chickens and swine in Portugal. J Antimicrob Chemother 2008 1.18
39 Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations. J Clin Microbiol 2004 1.16
40 CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents Chemother 2005 1.16
41 Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain. J Antimicrob Chemother 2013 1.14
42 Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl Environ Microbiol 2010 1.14
43 Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J Clin Microbiol 2005 1.10
44 [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis]. Enferm Infecc Microbiol Clin 2009 1.09
45 MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros 2011 1.08
46 Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. Int J Antimicrob Agents 2013 1.08
47 Global spread of the hyl(Efm) colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster. Antimicrob Agents Chemother 2010 1.07
48 Learning from mistakes: Taq polymerase contaminated with beta-lactamase sequences results in false emergence of Streptococcus pneumoniae containing TEM. J Antimicrob Chemother 2007 1.06
49 Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures. J Antimicrob Chemother 2006 1.05
50 Preservation of integron types among Enterobacteriaceae producing extended-spectrum beta-lactamases in a Spanish hospital over a 15-year period (1988 to 2003). Antimicrob Agents Chemother 2007 1.05
51 In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario? Antimicrob Agents Chemother 2011 1.04
52 High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother 2008 1.04
53 Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance. J Antimicrob Chemother 2003 1.03
54 Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains. J Antimicrob Chemother 2005 1.02
55 Commensal Enterobacteriaceae as reservoirs of extended-spectrum beta-lactamases, integrons, and sul genes in Portugal. Front Microbiol 2013 1.02
56 Melioidosis in traveler from Africa to Spain. Emerg Infect Dis 2013 1.01
57 High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 2007 1.00
58 Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother 2009 0.99
59 [High-risk clonal complexes CC2 and CC9 are widely distributed among Enterococcus faecalis hospital isolates recovered in Spain]. Enferm Infecc Microbiol Clin 2007 0.99
60 Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients. J Clin Microbiol 2012 0.99
61 Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization. Prev Med 2012 0.98
62 Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization. J Microbiol Methods 2010 0.98
63 Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance. Antimicrob Agents Chemother 2008 0.97
64 Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium. Diagn Microbiol Infect Dis 2010 0.97
65 Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient. J Clin Microbiol 2012 0.95
66 Normal mutation rate variants arise in a Mutator (Mut S) Escherichia coli population. PLoS One 2013 0.94
67 [Risk factors of influenza (H1N1) 2009 hospitalization and effectiveness of pharmaceutical and nonpharmaceutical interventions in its prevention: a case-control study]. Rev Esp Salud Publica 2011 0.94
68 Rapid detection of β-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic βLacta test. J Clin Microbiol 2014 0.94
69 International spread and persistence of TEM-24 is caused by the confluence of highly penetrating enterobacteriaceae clones and an IncA/C2 plasmid containing Tn1696::Tn1 and IS5075-Tn21. Antimicrob Agents Chemother 2009 0.94
70 Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clones. PLoS One 2012 0.94
71 Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B). Antimicrob Agents Chemother 2008 0.93
72 Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world. Front Microbiol 2013 0.93
73 Role of partner's infection in reinfection after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002 0.93
74 In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities. Antimicrob Agents Chemother 2003 0.92
75 Complex molecular epidemiology of extended-spectrum beta-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. J Antimicrob Chemother 2007 0.92
76 In117, an unusual In0-like class 1 integron containing CR1 and bla(CTX-M-2) and associated with a Tn21-like element. Antimicrob Agents Chemother 2006 0.91
77 Scarce evidence of yogurt lactic acid bacteria in human feces after daily yogurt consumption by healthy volunteers. Appl Environ Microbiol 2005 0.91
78 Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials. Expert Opin Pharmacother 2013 0.91
79 Contribution of IncFII and broad-host IncA/C and IncN plasmids to the local expansion and diversification of phylogroup B2 Escherichia coli ST131 clones carrying blaCTX-M-15 and qnrS1 genes. Antimicrob Agents Chemother 2012 0.90
80 Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin. J Antimicrob Chemother 2003 0.90
81 First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J Clin Microbiol 2011 0.89
82 Sociodemographic factors and clinical conditions associated to hospitalization in influenza A (H1N1) 2009 virus infected patients in Spain, 2009-2010. PLoS One 2012 0.89
83 Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain. J Antimicrob Chemother 2006 0.88
84 Staphylococcus aureus carrying mecC gene in animals and urban wastewater, Spain. Emerg Infect Dis 2014 0.88
85 Risk factors and effectiveness of preventive measures against influenza in the community. Influenza Other Respir Viruses 2012 0.88
86 In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients. Int J Antimicrob Agents 2012 0.87
87 Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain. J Clin Microbiol 2010 0.87
88 Leakage into Portuguese aquatic environments of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 2008 0.87
89 Allodemics. Lancet Infect Dis 2002 0.87
90 Association of composite IS26-sul3 elements with highly transmissible IncI1 plasmids in extended-spectrum-beta-lactamase-producing Escherichia coli clones from humans. Antimicrob Agents Chemother 2011 0.86
91 [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)]. Enferm Infecc Microbiol Clin 2008 0.85
92 In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method. Antimicrob Agents Chemother 2013 0.84
93 Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium. J Antimicrob Chemother 2002 0.84
94 Population structure and antimicrobial susceptibility of both nonpersistent and persistent Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. J Clin Microbiol 2013 0.84
95 Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains. J Clin Microbiol 2013 0.83
96 Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range Etest strips. J Clin Microbiol 2005 0.83
97 Persistent isolation of Salmonella Concord harbouring CTX-M-15, SHV-12 and QnrA1 in an asymptomatic adopted Ethiopian child in Spain also colonized with CTX-M-14- and QnrB-producing Enterobacteriaceae. J Antimicrob Chemother 2010 0.83
98 Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic. BMC Public Health 2013 0.82
99 High clonal diversity in a non-outbreak situation of clinical ESBL-producing Klebsiella pneumoniae isolates in the first national surveillance program in Cuba. Microb Drug Resist 2013 0.82
100 Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases. Antimicrob Agents Chemother 2003 0.82
101 Longer intestinal persistence of Enterococcus faecalis compared to Enterococcus faecium clones in intensive-care-unit patients. J Clin Microbiol 2008 0.82
102 Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2005 0.81
103 Counteracting antibiotic resistance: breaking barriers among antibacterial strategies. Expert Opin Ther Targets 2014 0.80
104 High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000-07). J Antimicrob Chemother 2009 0.80
105 Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors. J Antimicrob Chemother 2012 0.80
106 [Etiology of hospital-acquired infections in Spanish hospitals (EPINE, 1990-1999)]. Med Clin (Barc) 2002 0.79
107 [PER-1 multiresistant Pseudomonas aeruginosa strain in Spain]. Enferm Infecc Microbiol Clin 2006 0.79
108 International multicenter evaluation of the DiversiLab bacterial typing system for Escherichia coli and Klebsiella spp. J Clin Microbiol 2013 0.79
109 [Antimicrobial use in Spanish hospitals (EPINE, 1990-1999)]. Med Clin (Barc) 2002 0.79
110 Molecular characterization and genetic diversity of ESBL-producing Escherichia coli colonizing the migratory Franklin's gulls (Leucophaeus pipixcan) in Antofagasta, North of Chile. Microb Drug Resist 2014 0.78
111 Individual variability in finger-to-finger transmission efficiency of Enterococcus faecium clones. Microbiologyopen 2014 0.78
112 [Hospital antibiotic use and resistance: a relationship that is difficult to measure and complex to interpret]. Enferm Infecc Microbiol Clin 2009 0.78
113 Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient. Pediatr Pulmonol 2009 0.78
114 Emergence and long-lasting persistence of linezolid-resistant Enterococcus faecium-ST117 in an oncohematologic patient after a nine-day course of linezolid. Microb Drug Resist 2013 0.77
115 [Tolerance and heteroresistance in Gram-positive microorganisms]. Med Clin (Barc) 2010 0.77
116 Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization. Vaccine 2012 0.77
117 Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media. Clin Microbiol Infect 1997 0.77
118 [Polymorphism of mucA and fpvA genes in Pseudomonas aeruginosa isolates from cystic fibrosis patients: co-existence of genetically different variants]. Enferm Infecc Microbiol Clin 2010 0.77
119 [Detection of resistance phenotypes in gram-negative bacteria]. Enferm Infecc Microbiol Clin 2011 0.77
120 Prudent use of antimicrobials: have we done the best we can? The SEIMC and REIPI statement. Enferm Infecc Microbiol Clin 2010 0.76
121 Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol 2009 0.76
122 Bacteriologic diagnosis of respiratory tract infections. Clin Microbiol Infect 1996 0.76
123 Failure to detect Helicobacter pylori in vaginal secretions. Clin Microbiol Infect 1998 0.76
124 First report of macrolide resistance in a Mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain. Antimicrob Agents Chemother 2013 0.75
125 Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis. Ann Clin Microbiol Antimicrob 2004 0.75
126 [Mutant-prevention concentration: a new, clinically relevant parameter of antimicrobial activity?]. Enferm Infecc Microbiol Clin 2006 0.75
127 Pandemic influenza A (H1N1) in non-vaccinated, pregnant women in Spain (2009-2010). Matern Child Health J 2014 0.75
128 [The Spanish antibiogram committee (COESANT), in step with EUCAST]. Enferm Infecc Microbiol Clin 2013 0.75
129 [Evaluation of the ROBOBACT system for automatic processing of stool cultures]. Enferm Infecc Microbiol Clin 2003 0.75
130 [Acinetobacter baumannii: do they still deserve our attention?]. Enferm Infecc Microbiol Clin 2012 0.75
131 National dissemination of EUCAST guidelines is a shared responsibility. Clin Microbiol Infect 2020 0.75
132 Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One. Pediatr Infect Dis J 2022 0.75
133 [Streptococcus bovis, taxonomic status, clinical relevance and antimicrobial susceptibility]. Enferm Infecc Microbiol Clin 2013 0.75
134 [Daptomycin: a new therapeutic option for infections caused by Gram-positive bacteria. Introduction]. Med Clin (Barc) 2010 0.75
135 [Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)]. Enferm Infecc Microbiol Clin 2003 0.75